Nanosonics Limited (NNCSF)
USD 1.75
(0.0%)
USD 1.75
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 123.32 Million AUD | 14.55% |
| 2023 | 107.65 Million AUD | 26.13% |
| 2022 | 85.35 Million AUD | 28.31% |
| 2021 | 66.52 Million AUD | 11.93% |
| 2020 | 59.43 Million AUD | 20.85% |
| 2019 | 49.18 Million AUD | 15.52% |
| 2018 | 42.57 Million AUD | 11.94% |
| 2017 | 38.03 Million AUD | 16.34% |
| 2016 | 32.68 Million AUD | 57.95% |
| 2015 | 20.69 Million AUD | 27.71% |
| 2014 | 16.2 Million AUD | 10.36% |
| 2013 | 14.68 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 118.77 Million AUD | 10.33% |
| 2024 Q4 | 31.45 Million AUD | 0.0% |
| 2024 Q1 | 30.2 Million AUD | -49.35% |
| 2024 Q2 | 60.82 Million AUD | 101.36% |
| 2024 Q3 | 31.45 Million AUD | -48.29% |
| 2023 Q2 | 54.52 Million AUD | 103.0% |
| 2023 Q4 | 59.64 Million AUD | 108.21% |
| 2023 Q1 | 26.85 Million AUD | -43.84% |
| 2023 FY | 107.65 Million AUD | 26.13% |
| 2023 Q3 | 28.64 Million AUD | -47.46% |
| 2022 Q2 | 42.69 Million AUD | 98.36% |
| 2022 Q4 | 47.82 Million AUD | 103.19% |
| 2022 FY | 85.35 Million AUD | 28.31% |
| 2022 Q1 | 21.52 Million AUD | -42.89% |
| 2022 Q3 | 23.53 Million AUD | -44.88% |
| 2021 FY | 66.52 Million AUD | 11.93% |
| 2021 Q3 | 17.69 Million AUD | -46.5% |
| 2021 Q4 | 37.68 Million AUD | 113.03% |
| 2021 Q1 | 17.11 Million AUD | -47.25% |
| 2021 Q2 | 33.07 Million AUD | 93.18% |
| 2020 Q4 | 32.45 Million AUD | 92.33% |
| 2020 FY | 59.43 Million AUD | 20.85% |
| 2020 Q1 | 15.04 Million AUD | 11.17% |
| 2020 Q2 | 30.73 Million AUD | 104.22% |
| 2020 Q3 | 16.87 Million AUD | -45.09% |
| 2019 Q4 | 13.53 Million AUD | 0.0% |
| 2019 Q1 | 10.12 Million AUD | -6.96% |
| 2019 Q2 | 10.12 Million AUD | 0.0% |
| 2019 Q3 | 13.53 Million AUD | 33.75% |
| 2019 FY | 49.18 Million AUD | 15.52% |
| 2018 Q3 | 10.87 Million AUD | 13.45% |
| 2018 FY | 42.57 Million AUD | 11.94% |
| 2018 Q1 | 9.58 Million AUD | -7.91% |
| 2018 Q2 | 9.58 Million AUD | 0.0% |
| 2018 Q4 | 10.87 Million AUD | 0.0% |
| 2017 Q1 | 8.23 Million AUD | 0.47% |
| 2017 Q4 | 10.41 Million AUD | 0.0% |
| 2017 FY | 38.03 Million AUD | 16.34% |
| 2017 Q3 | 10.41 Million AUD | 26.45% |
| 2017 Q2 | 8.23 Million AUD | 0.0% |
| 2016 Q1 | 8.06 Million AUD | 26.88% |
| 2016 Q4 | 8.19 Million AUD | 0.0% |
| 2016 Q3 | 8.19 Million AUD | 1.58% |
| 2016 Q2 | 8.06 Million AUD | 0.0% |
| 2016 FY | 32.68 Million AUD | 57.95% |
| 2015 Q1 | 3.98 Million AUD | 20.17% |
| 2015 FY | 20.69 Million AUD | 27.71% |
| 2015 Q4 | 6.35 Million AUD | 0.0% |
| 2015 Q3 | 6.35 Million AUD | 59.38% |
| 2015 Q2 | 3.98 Million AUD | 0.0% |
| 2014 Q2 | 4.78 Million AUD | 0.0% |
| 2014 Q4 | 3.32 Million AUD | 0.0% |
| 2014 Q3 | 3.32 Million AUD | -30.58% |
| 2014 Q1 | 4.78 Million AUD | 81.46% |
| 2014 FY | 16.2 Million AUD | 10.36% |
| 2013 Q3 | 2.63 Million AUD | -44.0% |
| 2013 FY | 14.68 Million AUD | 0.0% |
| 2013 Q1 | 4.7 Million AUD | 0.0% |
| 2013 Q2 | 4.7 Million AUD | 0.0% |
| 2013 Q4 | 2.63 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -4206.878% |
| Ansell Limited | 495.5 Million USD | 75.112% |
| Ansell Limited | 495.5 Million USD | 75.112% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -48.93% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -7025.21% |
| Psykey, Inc. | 1.21 Million USD | -10062.508% |
| ConvaTec Group Plc | 910.31 Million USD | 86.453% |
| ConvaTec Group Plc | 872.5 Million USD | 85.866% |
| Encision Inc. | 3.77 Million USD | -3165.246% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -86860.814% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -112079.458% |
| Innovative MedTech Inc. | 6.09 Million USD | -1921.97% |
| LifePoint, Inc. | 7.42 Million USD | -1561.128% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -1842.353% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -14323.392% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -16883.091% |
| Reflect Scientific, Inc. | 1.06 Million USD | -11493.505% |
| SmileDirectClub, Inc. | 517 Million USD | 76.147% |
| Sector 10, Inc. | 39.84 Thousand USD | -309407.078% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 98.144% |
| SheerVision, Inc. | 2.33 Million USD | -5188.992% |
| United Health Products, Inc. | 2.42 Million USD | -4982.136% |
| Vasamed, Inc. | 4.67 Million USD | -2539.039% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -4713.795% |
| Yubo International Biotech Limited | 1.25 Million USD | -9703.836% |